Navigation Links
Court OKs Non-Prescription Sale of Certain 'Morning-After' Pills
Date:6/6/2013

WEDNESDAY, June 5 (HealthDay News) -- In the latest chapter of the legal wrangle over the non-prescription sale of "morning-after" pills, a New York appeals court on Wednesday ruled that some forms of the emergency contraception could be sold over-the-counter while the issue winds its way through the courts.

According to The Associated Press, the 2nd U.S. Circuit Court of Appeals in Manhattan ruled that two-pill versions of emergency contraception can be sold without a prescription or a restriction as to the buyer's age while the court mulls the validity of a U.S. government appeal.

However, a prior ruling by Brooklyn Judge Edward Korman that one-pill products -- including Plan B -- also could be sold without restrictions has now been suspended by the Manhattan court, the AP reported.

That suspension will stay in effect until the appeals court rules on the merits of the case later this year.

Korman issued his order April 5, igniting a battle over whether young girls could gain access to emergency contraception without a prescription. Soon after, on April 30, the U.S. Food and Drug Administration lowered to 15 the age at which people could purchase the Plan B One-Step pill over-the-counter -- two years younger than the prior age limit of 17.

A day later, on May 1, the Obama Administration stepped in to appeal the Korman decision. It is that appeal that is now working its way through the courts.

At the time of the FDA's move to lower the age limit, agency commissioner Dr. Margaret Hamburg said in a news release that, "research has shown that access to emergency contraceptive products has the potential to further decrease the rate of unintended pregnancies in the United States."

"The data reviewed by the agency demonstrated that women 15 years of age and older were able to understand how Plan B One-Step works, how to use it properly and that it does not prevent the transmission of a sexually transmitted disease," Hamburg said.

Plan B prevents implantation of a fertilized egg in a woman's uterus through the use of levonorgestrel, a synthetic form of the hormone progesterone used for decades in birth control pills. Plan B contains 1.5 milligrams of levonorgestrel, more than the pill contains. It is considered a form of birth control, not abortion.

Other brands of emergency contraception include Next Choice and Ella.

Planned Parenthood has long pushed for wider access to emergency contraception, with the group's president, Cecile Richards, calling it "an important step forward."

But conservative groups have objected to the move. In April, Janice Shaw Crouse, director of the Beverly LaHaye Institute, the think tank for the conservative women's group Concerned Women for America, called Korman's ruling "a political decision, made by those who stand to profit financially from an action that puts ideology ahead of the nation's girls and young women."

More information

There's more on emergency contraception at the World Health Organization.

-- E.J. Mundell

SOURCES: Janice Shaw Crouse, Ph.D., director and senior fellow, Beverly LaHaye Institute, Concerned Women for America; Planned Parenthood Federation of America, statement, April 30, 2013; The Associated Press


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stanford researchers discover the African cichlids noisy courtship ritual
2. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
3. America Awaits Supreme Courts Ruling on Health Care Reform
4. Supreme Court Surprises in Citizens United Montana Case, Delays Order
5. Courts Verdict on Health-Care Reform Holds Surprises, Legal Experts Say
6. Is Courts Health-Care Ruling a Wise Decision? It Depends...
7. Supreme Court Backs Much of Controversial Health Reform Law
8. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
9. Supreme Court Ruling Sets Stage for Full Rollout of Health-Care Reform Law
10. U.S. Appeals Court Backs Ruling Against Graphic Images on Cigarette Packs
11. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Court OKs Non-Prescription Sale of Certain 'Morning-After' Pills
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in 2009 ... have participated in the program every summer. The 2017 Serve, Learn, & Empower ... Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my daughter ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wall Centre Dental ... new patients from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, ... see the esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, ...
(Date:3/29/2017)... ... March 29, 2017 , ... How big is ... facilities, and who are the most active developers? , In the first ... Real Estate Insights (HREI) found that outpatient medical real estate development projects totaling ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 ... ... standard process in many scientific laboratories. The assembly protocols involve many repetitive steps ... well suited for automation, which enables the high-throughput needed, and results in a ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... New York , March 29, 2017 /PRNewswire/ ... recently published a report, which provides an exhaustive ... to the study, nearly 242 companies are functional ... fragmented and competitive. With the leading companies, such ... Purdue Pharma LP, focusing aggressively on various marketing ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... drugs market to grow at a CAGR of 2.87% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
Breaking Medicine Technology: